pubmed-article:19467928 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19467928 | lifeskim:mentions | umls-concept:C0028128 | lld:lifeskim |
pubmed-article:19467928 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
pubmed-article:19467928 | lifeskim:mentions | umls-concept:C0178719 | lld:lifeskim |
pubmed-article:19467928 | lifeskim:mentions | umls-concept:C0007745 | lld:lifeskim |
pubmed-article:19467928 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
pubmed-article:19467928 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:19467928 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:19467928 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
pubmed-article:19467928 | lifeskim:mentions | umls-concept:C0079411 | lld:lifeskim |
pubmed-article:19467928 | lifeskim:mentions | umls-concept:C0055951 | lld:lifeskim |
pubmed-article:19467928 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:19467928 | pubmed:dateCreated | 2009-11-2 | lld:pubmed |
pubmed-article:19467928 | pubmed:abstractText | The effect of Clostridium perfringens alpha-toxin on production of tumor necrosis factor (TNF)-alpha and nitric oxide (NO) in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells was studied. The pretreatment of wild type alpha-toxin, but not the inactive mutant, significantly decreased LPS-induced TNF-alpha and NO production. alpha-Toxin inhibited the expression of TNF-alpha and an inducible type of NO synthase protein and mRNA. Furthermore, it inhibited the phosphorylation of IkappaB-alpha and p65 NF-kappaB subunit, and the NF-kappaB luciferase reporter gene activity in LPS-stimulated cells. The pretreatment of alpha-toxin increased the level of intracellular ceramide. Taken together, Clostridium perfringens alpha-toxin pretreatment was suggested to inhibit LPS-induced TNF-alpha and NO production through the inhibition of NF-kappaB activation. The relationship between alpha-toxin-induced intracellular ceramide generation and the NF-kappaB inhibition is discussed. | lld:pubmed |
pubmed-article:19467928 | pubmed:language | eng | lld:pubmed |
pubmed-article:19467928 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19467928 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19467928 | pubmed:month | Dec | lld:pubmed |
pubmed-article:19467928 | pubmed:issn | 1618-0607 | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:OdaMasatakaM | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:NagahamaMasah... | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:SakuraiJunJ | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:KomatsuTakayu... | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:YokochiTakash... | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:YoshidaTomoak... | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:KoideNaokiN | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:NaikiYoshikaz... | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:TumurkhuuGant... | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:DagvadorjJarg... | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:NomanAbu... | lld:pubmed |
pubmed-article:19467928 | pubmed:author | pubmed-author:Iftekar-E-Khu... | lld:pubmed |
pubmed-article:19467928 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19467928 | pubmed:volume | 299 | lld:pubmed |
pubmed-article:19467928 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19467928 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19467928 | pubmed:pagination | 554-62 | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:meshHeading | pubmed-meshheading:19467928... | lld:pubmed |
pubmed-article:19467928 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19467928 | pubmed:articleTitle | The inhibition of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by Clostridium perfringens alpha-toxin and its relation to alpha-toxin-induced intracellular ceramide generation. | lld:pubmed |
pubmed-article:19467928 | pubmed:affiliation | Department of Microbiology and Immunology, Aichi Medical University, School of Medicine, Nagakute, Aichi 480-1195, Japan. | lld:pubmed |
pubmed-article:19467928 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19467928 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19467928 | lld:entrezgene |